Contact trans-scleral diode laser cyclophotocoagulation treatment for refractory glaucomas in the Indian population.
dc.contributor.author | Gupta, V | en_US |
dc.contributor.author | Agarwal, H C | en_US |
dc.date.accessioned | 2000-12-09 | en_US |
dc.date.accessioned | 2009-05-29T08:59:52Z | |
dc.date.available | 2000-12-09 | en_US |
dc.date.available | 2009-05-29T08:59:52Z | |
dc.date.issued | 2000-12-09 | en_US |
dc.description.abstract | PURPOSE: This study aimed to evaluate the clinical efficacy of contact diode trans-scleral cyclophotocoagulation (TSCPC) for treatment of refractory glaucomas. METHOD: Fifty two eyes of 52 patients, (post-penetrating keratoplasty glaucoma: 16 eyes; adherent leucoma with secondary glaucoma: 8 eyes; aphakic glaucoma: 6 eyes; neovascular glaucoma: 6 eyes; narrow angle glaucoma: 6 eyes; and other secondary glaucomas: 10 eyes) were followed up from 3.5-18 months (average 12 months) after TSCPC. The treatment parameters using the contact G probe were--energy: 3-4J; area: 40 spots spread over 360 degrees; site: 1.2-1.5 mm posterior to limbus. Retreatments (22 eyes; 42%) were given whenever intraocular pressure (IOP) exceeded 22 mmHg despite maximum tolerable topical therapy. RESULTS: IOP decreased from a baseline of 44.7 (+/- 7.3) mmHg to 15 (+/- 3.7) mmHg at first week and was 15.2 +/- (8.2) mmHg at the last follow up. Successful control of IOP (< 22 mmHg) occurred in 30 (58%) eyes after a single treatment and in 48 (92%) eyes following retreatment. Complications included reduction in visual acuity from light perception (LP) only to no light perception (NLP) in two eyes and phthisis bulbi in one eye. CONCLUSION: Contact trans-scleral diode laser cyclophotocoagulation is effective in lowering IOP in eyes with intractable glaucoma with few side effects in Indian subjects. | en_US |
dc.description.affiliation | Dr. Rajendra Prasad Centre for Ophthalmic Sciences, New Delhi, India. gupta_v@mailcity.com | en_US |
dc.identifier.citation | Gupta V, Agarwal HC. Contact trans-scleral diode laser cyclophotocoagulation treatment for refractory glaucomas in the Indian population. Indian Journal of Ophthalmology. 2000 Dec; 48(4): 295-300 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/71104 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.ijo.in | en_US |
dc.subject.mesh | Adolescent | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Ciliary Body --physiopathology | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Glaucoma --epidemiology | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | India --epidemiology | en_US |
dc.subject.mesh | Intraocular Pressure --physiology | en_US |
dc.subject.mesh | Laser Coagulation --methods | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Prevalence | en_US |
dc.subject.mesh | Retrospective Studies | en_US |
dc.subject.mesh | Sclera --surgery | en_US |
dc.subject.mesh | Visual Acuity | en_US |
dc.title | Contact trans-scleral diode laser cyclophotocoagulation treatment for refractory glaucomas in the Indian population. | en_US |
dc.type | Comparative Study | en_US |
dc.type | Journal Article | en_US |
Files
License bundle
1 - 1 of 1